Why is methotrexate the first selection in disease-modifying antirheumatic drug therapy? Comment on the article by Wolfe et al
Carlo V. Caballero-UribeVolume:
12
Year:
1999
Language:
english
Pages:
1
DOI:
10.1002/1529-0131(199904)12:23.0.co;2-9
File:
PDF, 62 KB
english, 1999